These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32160194)

  • 21. Capturing Protein-Ligand Recognition Pathways in Coarse-Grained Simulation.
    Dandekar BR; Mondal J
    J Phys Chem Lett; 2020 Jul; 11(13):5302-5311. PubMed ID: 32520567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring human-guided strategies for reaction network exploration: Interactive molecular dynamics in virtual reality as a tool for citizen scientists.
    Shannon RJ; Deeks HM; Burfoot E; Clark E; Jones AJ; Mulholland AJ; Glowacki DR
    J Chem Phys; 2021 Oct; 155(15):154106. PubMed ID: 34686059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSI-DOCK: towards highly efficient and accurate flexible ligand docking.
    Pei J; Wang Q; Liu Z; Li Q; Yang K; Lai L
    Proteins; 2006 Mar; 62(4):934-46. PubMed ID: 16395666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
    Liu H; Yao X; Wang C; Han J
    Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining Virtual Reality Visualization with Ensemble Molecular Dynamics to Study Complex Protein Conformational Changes.
    Juárez-Jiménez J; Tew P; O Connor M; Llabrés S; Sage R; Glowacki D; Michel J
    J Chem Inf Model; 2020 Dec; 60(12):6344-6354. PubMed ID: 33180485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations.
    Okimoto N; Futatsugi N; Fuji H; Suenaga A; Morimoto G; Yanai R; Ohno Y; Narumi T; Taiji M
    PLoS Comput Biol; 2009 Oct; 5(10):e1000528. PubMed ID: 19816553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic Docking of Macrocycles in Bound and Unbound Protein Structures with DynaDock.
    Meixner M; Zachmann M; Metzler S; Scheerer J; Zacharias M; Antes I
    J Chem Inf Model; 2022 Jul; 62(14):3426-3441. PubMed ID: 35796228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDOCKER and λ-dynamics for prospective prediction in D₃R Grand Challenge 2.
    Ding X; Hayes RL; Vilseck JZ; Charles MK; Brooks CL
    J Comput Aided Mol Des; 2018 Jan; 32(1):89-102. PubMed ID: 28884249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations.
    Buch I; Giorgino T; De Fabritiis G
    Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10184-9. PubMed ID: 21646537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
    Yusuf M; Mohamed N; Mohamad S; Janezic D; Damodaran KV; Wahab HA
    J Chem Inf Model; 2016 Jan; 56(1):82-100. PubMed ID: 26703840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors.
    Kunze J; Todoroff N; Schneider P; Rodrigues T; Geppert T; Reisen F; Schreuder H; Saas J; Hessler G; Baringhaus KH; Schneider G
    J Chem Inf Model; 2014 Mar; 54(3):987-91. PubMed ID: 24528206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Joint X-ray/neutron crystallographic study of HIV-1 protease with clinical inhibitor amprenavir: insights for drug design.
    Weber IT; Waltman MJ; Mustyakimov M; Blakeley MP; Keen DA; Ghosh AK; Langan P; Kovalevsky AY
    J Med Chem; 2013 Jul; 56(13):5631-5. PubMed ID: 23772563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase.
    Tran DT; Le LT; Truong TN
    J Comput Aided Mol Des; 2013 Aug; 27(8):689-95. PubMed ID: 23979194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of shape similarity based pose prediction method in D3R Grand Challenge 2015.
    Kumar A; Zhang KY
    J Comput Aided Mol Des; 2016 Sep; 30(9):685-693. PubMed ID: 27484214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors.
    Chavan S; Bhayye S; Sobhia ME
    Mol Divers; 2011 Nov; 15(4):979-87. PubMed ID: 21922291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein.
    Li H; Li C
    J Comput Chem; 2010 Jul; 31(10):2014-22. PubMed ID: 20166125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures.
    Bolia A; Gerek ZN; Ozkan SB
    J Chem Inf Model; 2014 Mar; 54(3):913-25. PubMed ID: 24380381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ReFlexIn: a flexible receptor protein-ligand docking scheme evaluated on HIV-1 protease.
    Leis S; Zacharias M
    PLoS One; 2012; 7(10):e48008. PubMed ID: 23110159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir.
    Yu Y; Wang J; Shao Q; Shi J; Zhu W
    Sci Rep; 2015 May; 5():10517. PubMed ID: 26012849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized Virtual Screening Workflow: Towards Target-Based Polynomial Scoring Functions for HIV-1 Protease.
    Pintro VO; de Azevedo WF
    Comb Chem High Throughput Screen; 2017; 20(9):820-827. PubMed ID: 29165067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.